Davis, Margot |
| Recruiting | 3 | 390 | Canada, US | Abatacept plus, Orencia, Placebo | Massachusetts General Hospital, Bristol-Myers Squibb | Myocarditis Acute, Cancer | 11/26 | 04/27 | | |
RADICALPC, NCT03127631: A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients |
|
|
| Recruiting | N/A | 6000 | Canada, US, RoW | Nutrition, Exercise, Smoking cessation, Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), ACE inhibitor | McMaster University, Prostate Cancer Canada, Canadian Cancer Society (CCS) | Prostate Cancer, Cardiovascular Disease | 12/26 | 12/26 | | |
Appel-Cresswell, Silke |
TAP, NCT03968133: Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic |
|
|
| Active, not recruiting | 2 | 61 | Canada | Probiotic, Ecologic® BARRIER 849, Placebo | University of British Columbia, The W. Garfield Weston Foundation | Parkinson Disease, Anxiety | 05/23 | 12/23 | | |
KIM, NCT05469997: Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome |
|
|
| Active, not recruiting | N/A | 50 | Canada | Mediterranean-Ketogenic Diet, MeDi-KD, Mediterranean diet supplemented with medium-chain triglyceride oil, MeDi-MCT | University of British Columbia, Weston Family Foundation | Parkinson Disease | 02/25 | 07/25 | | |
| Recruiting | N/A | 60 | Canada | Exercise, Meditation, Diet | University of British Columbia, The Jack and Darlene Poole Foundation | Healthy Aging | 01/25 | 01/25 | | |
| Not yet recruiting | N/A | 40 | NA | Mediterranean-style diet | University of British Columbia, Weston Family Foundation | Parkinson Disease, Diet, Healthy, Gut Microbiome, Gastrointestinal Microbiome | 12/27 | 12/27 | | |
Gupta, Dipti |
| Recruiting | 3 | 390 | Canada, US | Abatacept plus, Orencia, Placebo | Massachusetts General Hospital, Bristol-Myers Squibb | Myocarditis Acute, Cancer | 11/26 | 04/27 | | |
NCT06355661: A Study for Assessing the Efficacy and Safety ParActin® in Individuals With Upper Respiratory Tract Infections |
|
|
| Recruiting | N/A | 120 | RoW | ParActin®: 300 mg + MCC: 100 mg (± 10%) per Capsule, MCC: 400 mg (± 10%) per Capsule | Vedic Lifesciences Pvt. Ltd. | Upper Respiratory Tract Infections | 07/24 | 07/24 | | |
NCT05835375: A Study to Evaluate the Efficacy of EQ-778 on Upper Respiratory Tract Health Status in Healthy Adults |
|
|
| Recruiting | N/A | 374 | RoW | EQ-778, Placebo | Vedic Lifesciences Pvt. Ltd. | Upper Respiratory Tract Infection | 04/24 | 04/24 | | |
Powell, Madeleine |
| Recruiting | N/A | 60 | Canada | Exercise, Meditation, Diet | University of British Columbia, The Jack and Darlene Poole Foundation | Healthy Aging | 01/25 | 01/25 | | |